Top companies earn 80% of revenue in IVD market September 11, 2020 -- Most of the revenue in the IVD market is generated by fewer than 20 companies, according to a recent report by IVD market research firm Kalorama Information, a sister company of LabPulse.com, explains Bruce Carlson of Kalorama. Discuss
Experts draw lessons from FDA's hydroxychloroquine EUA controversy September 8, 2020 -- Public health and regulatory experts advocated for changes to the U.S. Food and Drug Administration (FDA) emergency use authorization (EUA) process in a viewpoint published online August 31 in the Journal of the American Medical Association. They offer a set of recommendations to improve the process going forward as more COVID-19 vaccines and treatments emerge. Discuss
Detecting SARS-CoV-2 in blood may be early indicator of severe disease September 2, 2020 -- A blood test that measures SARS-CoV-2 RNA when patients are admitted to the hospital with COVID-19 symptoms can be a powerful diagnostic tool to predict how severe their disease will be, according to a study published in Clinical Infectious Diseases on August 28. Patients without viral RNA in their blood have a good chance at rapid recovery, concluded researchers from Karolinska Institutet and Danderyd Hospital. Discuss
Top 5 facts about the IVD market September 1, 2020 -- The market for IVD tests is vital and rapidly changing. IVD tests serve as a gateway to numerous other healthcare segments, and attract significant research and development spending and venture capital investments. Bruce Carlson of Kalorama Information explains the five facts that make the IVD market unique. Discuss
FDA authorizes Abbott's COVID-19 real-time antigen test August 27, 2020 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for a COVID-19 antigen test developed by Abbott Diagnostics Scarborough from which results can be read directly from the testing card.
Genetic testing cut adverse events in heart patients August 27, 2020 -- Personalized genetic testing led to a 34% decrease in the number of patients who had serious adverse events following balloon angioplasties, according to results published August 25 in the Journal of the American Medical Association. Discuss
Point-of-care testing leads South Korea's response to COVID-19 August 24, 2020 -- What was the secret to South Korea's success in controlling the COVID-19 pandemic? A new study indicates that point-of-care testing played an important role in reducing the spread of SARS-CoV-2 there compared to the U.S., which has experienced 47 times the number of cases and almost 80 times the number of deaths. Discuss